Literature DB >> 11780404

All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.

Y Qin1, A Zhou, X Ben, J Shen, Y Liang, F Li.   

Abstract

OBJECTIVE: To determine whether all-trans retinoic acid (atRA) exerts an inhibitory effect on rats with pulmonary hypertension induced by monocrotaline.
METHODS: All rats were given a single subcutaneous injection of either monocrotaline (60 mg/kg) or saline. Monocrotaline-injected rats received either atRA (30 mg.kg-1.day-1) or saline through oral-gastro intubation. On Days 7, 14, 21, and 28 respectively after monocrotaline injection, cardiovascular catheters were inserted to examine the mean pulmonary artery pressure of rats in each group. Meanwhile, the matrix metalloproteinase-1 (MMP-1) mRNA expression and hydroxyproline content in the main pulmonary artery were determined by RT-PCR and chromometry, respectively.
RESULTS: The mean pulmonary artery pressure of rats in the model group increased significantly on day 21 and reached a peak on Day 28 compared with the control group (25.7 +/- 4.3 mm Hg vs 15.1 +/- 1.5 mm Hg and 38.5 +/- 6.4 mm Hg vs 16.4 +/- 2.0 mm Hg, P < 0.01). MMP-1 mRNA overexpression was present on Day 14 (0.72 +/- 0.15 vs 0.39 +/- 0.08, P < 0.01) and was rapidly down-regulated on Day 21 and 28 compared with Day 14, but was still higher than that in the control. The hydroxyoroline content of the main pulmonary artery dropped significantly on Day 14 (4.01 +/- 1.13 micrograms/mg vs 5.10 +/- 0.91 micrograms/mg, P < 0.05) and increased significantly on Days 21 and 28 compared with the control. atRA inhibited the MMP-1 mRNA overexpression from Day 14 to Day 28 and reduced the hydroxyproline content (5.59 +/- 0.70 micrograms/mg vs 7.96 +/- 1.13 micrograms/mg and 7.77 +/- 0.96 micrograms/mg vs 9.93 +/- 1.27 micrograms/mg, P < 0.01) and the mean pulmonary artery pressure compared with the model group (19.6 +/- 3.2 mm Hg vs 25.7 +/- 4.3 mm Hg and 26.3 +/- 4.6 mm Hg vs 38.5 +/- 6.4 mm Hg, P < 0.01).
CONCLUSION: atRA inhibits MMP-1 overexpression and the accumulation of collagen, which might elicit favorable geometric remodeling in rat pulmonary hypertension induced by monocrotaline.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780404

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Retinoic acid inhibits airway smooth muscle cell migration.

Authors:  Regina M Day; Young H Lee; Ah-Mee Park; Yuichiro J Suzuki
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-02       Impact factor: 6.914

2.  A wrinkle in time: circadian biology in pulmonary vascular health and disease.

Authors:  Andrew J Bryant; Elnaz Ebrahimi; Amy Nguyen; Christopher A Wolff; Michelle L Gumz; Andrew C Liu; Karyn A Esser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-01       Impact factor: 5.464

3.  Plasma levels of retinoids, carotenoids and tocopherols in patients with mild obstructive sleep apnoea.

Authors:  Regina M Day; Ismael A Matus; Yuichiro J Suzuki; Kyung-Jin Yeum; Jian Qin; Ah-Mee Park; Vivek Jain; Tunay Kuru; Guangwen Tang
Journal:  Respirology       Date:  2009-09-16       Impact factor: 6.424

4.  Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.

Authors:  Soni Pullamsetti; Stefanie Krick; Hüseyin Yilmaz; Hossein Ardeschir Ghofrani; Christian Schudt; Norbert Weissmann; Beate Fuchs; Werner Seeger; Friedrich Grimminger; Ralph Theo Schermuly
Journal:  Respir Res       Date:  2005-11-01

5.  Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.

Authors:  Toshikazu Ito; Erquan Zhang; Ayaka Omori; Jane Kabwe; Masako Kawai; Junko Maruyama; Amphone Okada; Ayumu Yokochi; Hirofumi Sawada; Yoshihide Mitani; Kazuo Maruyama
Journal:  BMC Pulm Med       Date:  2021-11-20       Impact factor: 3.317

6.  Serine carboxypeptidase SCPEP1 and Cathepsin A play complementary roles in regulation of vasoconstriction via inactivation of endothelin-1.

Authors:  Xuefang Pan; Lubov Grigoryeva; Volkan Seyrantepe; Junzheng Peng; Katrin Kollmann; Johanne Tremblay; Julie L Lavoie; Aleksander Hinek; Torben Lübke; Alexey V Pshezhetsky
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

Review 7.  Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.

Authors:  Andrew J Bryant; Borna Mehrad; Todd M Brusko; James D West; Lyle L Moldawer
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.